Resolving Ethical Issues in Stem Cell Clinical Trials: The Example of Parkinson Disease

Journal of Law, Medicine and Ethics 38 (2):257-266 (2010)
Abstract
Clinical trials of stem cell transplantation raise ethical issues that are intertwined with scientific and design issues, including choice of control group and intervention, background interventions, endpoints, and selection of subjects. We recommend that the review and IRB oversight of stem cell clinical trials should be strengthened. Scientific and ethics review should be integrated in order to better assess risks and potential benefits. Informed consent should be enhanced by assuring that participants comprehend key aspects of the trial. For the trial to yield generalizable knowledge, negative findings and serious adverse events must be reported
Keywords No keywords specified (fix it)
Categories (categorize this paper)
Options
 Save to my reading list
Follow the author(s)
My bibliography
Export citation
Find it on Scholar
Edit this record
Mark as duplicate
Revision history Request removal from index
 
Download options
PhilPapers Archive


Upload a copy of this paper     Check publisher's policy on self-archival     Papers currently archived: 9,351
External links
  • Through your library Configure
    References found in this work BETA
    Citations of this work BETA
    John A. Robertson (2010). Introduction. Journal of Law, Medicine and Ethics 38 (2):175-190.
    Similar books and articles
    Analytics

    Monthly downloads

    Added to index

    2010-08-11

    Total downloads

    9 ( #128,813 of 1,088,398 )

    Recent downloads (6 months)

    1 ( #69,601 of 1,088,398 )

    How can I increase my downloads?

    My notes
    Sign in to use this feature


    Discussion
    Start a new thread
    Order:
    There  are no threads in this forum
    Nothing in this forum yet.